Convatec Group (LON:CTEC) Stock: Insider Jens Viebke Buys 24,400 Shares

Key Points

• Insider purchase: Convatec Group insider Jens Viebke bought 24,400 shares at GBX 230 each, for a total investment of £56,120.
• Stock performance: Shares opened at GBX 235.60, with a market capitalization of approximately £4.52 billion and a 52-week range of GBX 193 to GBX 259.30.
• Analyst outlook: Convatec has a consensus “Moderate Buy” rating from analysts, with eight Buy ratings, one Hold rating, and an average price target of GBX 305.44.

Convatec Group PLC (LON:CTEC - Get Free Report) insider Jens Viebke bought 24,400 shares of the firm's stock in a transaction that occurred on Tuesday, October 13th. The stock was purchased at an average price of GBX 230 per share, with a total value of £56,120.

Convatec Group Stock Performance

Shares of LON CTEC opened at GBX 235.60 on Wednesday. The company has a market capitalization of £4.52 billion, a PE ratio of 38.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93. The company's fifty day moving average price is GBX 223.19 and its 200 day moving average price is GBX 217.57. Convatec Group PLC has a 1 year low of GBX 193 and a 1 year high of GBX 259.30.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CTEC shares. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a GBX 315 price target on shares of Convatec Group in a report on Monday, August 3rd. Berenberg Bank dropped their price objective on Convatec Group from GBX 340 to GBX 335 and set a "buy" rating on the stock in a report on Friday, September 11th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 315 price objective on shares of Convatec Group in a research report on Wednesday, August 5th. Peel Hunt restated an "add" rating and issued a GBX 270 price objective on shares of Convatec Group in a research report on Tuesday, August 4th. Finally, Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 300 target price on shares of Convatec Group in a research note on Wednesday, August 5th. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of GBX 305.44.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.